Anthelos finished the Hungarian Multi-Program supporting technological platform and real estate development
AnthelosLatest News
Up to date information on our latest breakthroughs and developments.
Anthelos extended its chemical potential by applying optimized protocols to synthesize novel oligonucleotide synthons
ANTHELOS to attend the BIO 2024 International Convention, June 16-20, 2025
Anthelos extended its chemical potential by applying optimized protocols to synthesize novel oligonucleotide synthons
Anthelos has set up a 3D printer
06/09/2023
Anthelos has set up a 3D printer capable of applying millions of color with micrometer precision in the frame of a GINOP grant
Supporting the development of micro, small and medium-sized enterprises to adapt to modern business and production challenges in the most disadvantaged regions.
Anthelos widened its chemical portfolio with AK Scientific Inc. (Union City, California, USA)
New molecular diagnostic product
06/10/2021
Anthelos has developed a novel molecular diagnostic product, the Microbiome genomic analysis kit
Anthelos is proud to anounce that from January 2021 the company became the local distributor of TargetMol company (www.targetmol.com) in Hungary.
Within the first few weeks after Anthelos foundation, our team of specialists validated a real-time Reverse Transcriptase PCR (QPCR) assay for the specific detection of the SARS-CoV-2 virus using saliva, sputum and nasal swabs.